Dr. Bhaskar Chandu Kolla, MD

Dr. Kolla practices at Osceola Medical Center in Osceola, Wisconsin, part of Osceola Medical Center.

Dr. Kolla's NPI, 1659535615, was assigned on July 17, 2008. Dr. Kolla holds Minnesota license 56191.

Dr. Kolla's primary practice is Osceola Medical Center, at 2600 65th Avenue, Osceola, WI 54020 in Polk County. The practice phone is (715) 294-2111.

Dr. Kolla's primary practice is Osceola Medical Center in Osceola, Wisconsin, part of Osceola Medical Center. Dr. Kolla is also affiliated with Methodist Hospital. The medical group on file is HealthPartners. Dmand AI also links Dr. Kolla to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolla practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kolla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kolla's licenses on file in 3 states: Minnesota, Illinois and Wisconsin.

CMS data shows 656 Medicare services from Dr. Kolla across 7 procedure codes in 2024, for 160 Medicare patients. Medicare paid $41,526 for them.

CMS counts 160 Medicare patients who saw Dr. Kolla in 2024. The largest group is 65 to 74, with 84 patients. 63% of them have high blood pressure, and 56% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolla's median patient age at 71, with 57% women.

In 2024, Dr. Kolla wrote 1,125 Medicare Part D claims for 142 patients. 83% of them were for generic drugs. CMS names the drug for 897 of them, across 31 drugs with 11 or more claims each, at $2,121,114 in total drug cost. In 2023, CMS named 933 claims across 32 drugs.

Dr. Kolla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kolla as offering telehealth.

Dmand AI links 10 papers to Dr. Kolla, published from 2016 to 2021. 2020 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents, Immunological and Lymphoma, Mantle-Cell. Dr. Kolla's most frequent co-authors are Veronika Bachanova, MD, David Alan Bond, MD and Timothy S. Fenske, MD.

CMS Open Payments shows 2 general payments to Dr. Kolla from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Histosonics, Inc. paid the most, $233.